Topics
A to Z
Data &
 Statistics
Forms &
Publications
News &
Advisories
Licensing &
Certification
Rules &
Regulations
Public Health
Directory

Chlamydia trachomatis and Neisseria gonorrhoeae, TMA amplified

Updated

6/30/2015

Other Names Chlamydia (CT) Combo Test; Chlamydia and Gonorrhea Screen; Gonorrhea (GC) Combo Test
How to Order
Check the “Chlamydia/Gonorrhea by NAAT” box under the “Other” heading on the Virology/Immunology Request (form 42).  
Availability
All clients
Methodology
Transcription-Mediated Amplification; Nucleic Acid Hybridization
Performed
Monday through Friday
Time to Reporting
1-3 days
CPT Code
87801


Specimen Collection Details

Collection
Detailed instructions for collecting, storting, and transporting each acceptable specimen type is provided in the OSPHL Instructions for CT/GC Testing located here: https://public.health.oregon.gov/LaboratoryServices/Documents/OSPHL-CTGC-Instructions.pdf.
Optimal Volume
2 mL urine, not applicable for swabs.
Minimum Volume
2 mL urine, not applicable for swabs.
Handling
All sample types may be stored and transported at 4-30°C.  All sample types are stable for 30 days. 
Transport
All sample types may be stored and transported at 4-30°C.  All sample types are stable for 30 days. 
Transport at ambient or refrigerated temperatures.
Rejection Criteria
Specimen rejection criteria specific to CT/GC samples is provided in the OSPHL Instructions for CT/GC Testing located here: https://public.health.oregon.gov/LaboratoryServices/Documents/OSPHL-CTGC-Instructions.pdf.
Comments
The OSPHL has validated the modification of the current FDA approved procedure for CT/GC testing to include rectal and pharyngeal swabs. Only specimen sources detailed in the OSPHL Instructions for CT/GC Testing document provided above are acceptable for testing at the OSPHL.